Treatment
Treatment A clinical trials
We’re tracking 8,313 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT05465031RecruitingPhase 4
Testing heart-protection medicine during breast cancer treatment
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
Opole, Opole VoivodeshipAges 18 years+ - NCT06028087Recruiting
Blood Clot Prevention Study in Myeloma Patients
This study looks at how blood thinners are used in people with newly diagnosed multiple myeloma. The goal is to find better ways to prevent blood clots during treatment.
RomaAges 18 years+ - NCT06567353Recruiting
Heat-based immunotherapy for breast cancer liver metastases
This trial tests a new treatment that uses heat to target liver tumors and boost the immune system. It is for women with breast cancer that has spread to the liver who cannot have or do not want surgery.
ShanghaiAges 18–75 - NCT07301710RecruitingPhase 1/Phase 2
Low-tech treatments for sleep apnea
This study tests simple, low-tech treatments (like exercises) for sleep apnea. It's for people who are newly diagnosed or whose current treatment isn't working, and who are willing to pause their usual treatment for 3 months.
Bethesda, MarylandAges 18–65 - NCT07304518RecruitingPhase 2
PRT-064040 nasal spray for migraine in adults
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
Beijing, Beijing MunicipalityAges 18–75 - NCT07301749Recruiting
Study of VCFix device for spine fractures
This trial tests a new device called VCFix to treat a single broken vertebra in the mid-to-lower back. It aims to see if the device is safe and effective for relieving pain and restoring spine function.
ChambéryAges 21–85 - NCT07298447RecruitingPhase 3
Donidalorsen for children with hereditary angioedema
This study tests a new medicine, donidalorsen, to prevent swelling attacks in children ages 2 to 11 with hereditary angioedema (HAE). If your child has HAE type 1 or 2, this trial may help find a treatment option.
Santa Monica, CaliforniaAges 2–11 - NCT06705387RecruitingPhase 2
Dupilumab vs steroid for narrow EoE in young people
This study compares two treatments for EoE that has caused narrowing in the esophagus: dupilumab (a biologic injection) versus a topical corticosteroid (a swallowed steroid). It aims to see which works better for teens and young adults to improve swallowing and reduce inflammation.
Aurora, ColoradoAges 12–25 - NCT07299916Enrolling by invitation
Brain stimulation and virtual reality for anxiety disorders
This trial tests if a combination of non-invasive brain stimulation (tDCS) and virtual reality meditation can reduce anxiety in people with Generalized Anxiety Disorder or related conditions. It aims to find a new, non-medication way to help manage symptoms.
Hong KongAges 16–70 - NCT07301216Recruiting
Copper in urine after stopping Wilson disease therapy
This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.
New Haven, ConnecticutAges 18 years+ - NCT07305090Recruiting
Gut GVHD biomarker study for transplant patients
This trial aims to develop a test using multiple biomarkers to predict how well patients will respond to treatment for acute graft-versus-host disease (GVHD) affecting the gut. It focuses on patients who are receiving an allogeneic stem cell transplant.
Bologna, BolognaAges 12 years+ - NCT07299539Recruiting
Treatment study for enterococcus faecalis bloodstream infection
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
StrasbourgAges 18 years+ - NCT07305519Recruiting
Can supplements prevent early birth for short cervix?
This study tests if taking a combination of magnesium, a natural supplement (palmitoylethanolamide), hyaluronic acid, and vitamins B6 and D can help prevent preterm birth in women with a shorter-than-ideal cervix.
Rome, RMAges 18 years+ - NCT07299591Recruiting
Antibiotic levels in hip infection spacer study
This study is testing a new way to measure how well antibiotics reach the infected area around a hip implant during a two-stage replacement surgery. If you are already planning this surgery, researchers want to see if the levels of antibiotics in the spacer are high enough to fight the infection.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07304401Recruiting
Closed-loop spinal cord stimulation for chemo-related nerve pain
This trial tests whether a new type of spinal cord stimulator (SCS) can reduce pain caused by chemotherapy. If you have lasting nerve pain after cancer treatment and standard pain medications haven't helped, this device might offer relief.
ArnhemAges 18 years+ - NCT07304024RecruitingPhase 1/Phase 2
Testing a drug and sound therapy for age-related hearing difficulty
This trial tests whether a combination of an antihistamine (clemastine fumarate) and specially designed sounds can improve how the brain processes hearing in middle-aged adults with mild hearing loss. It might help if you have trouble understanding speech in noisy settings.
Aurora, ColoradoAges 45–65 - NCT07300514RecruitingPhase 3
Golidocitinib vs placebo for T-cell lymphoma maintenance
This trial tests if taking golidocitinib pills after first treatment helps keep peripheral T-cell lymphoma from coming back. You'll either get the study drug or a placebo (no active drug), and your doctor will watch how you do.
ShanghaiAges 18 years+ - NCT07301008RecruitingPhase 4
Rimegepant to prevent predictable trigger-induced migraines
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
McLean, VirginiaAges 18 years+ - NCT07301268RecruitingPhase 2
GI-102 with or without pembrolizumab before brain surgery
This trial is testing a new drug called GI-102, given alone or with pembrolizumab, before surgery for a type of brain tumor called glioblastoma or grade 4 astrocytoma. The goal is to see if these drugs can help shrink the tumor before it's removed.
Rochester, MinnesotaAges 18 years+ - NCT07299123Enrolling by invitationPhase 1/Phase 2
Stem cell transplant with cord cells for severe aplastic anemia
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
BeijingAges 6–60 - NCT07298941RecruitingPhase 2
Sleep treatment to help with chronic low back pain
This study tests if improving sleep can help people with chronic low back pain feel better and cope with pain. It involves a sleep-focused treatment program and looks at how it affects your overall well-being.
Charlottesville, VirginiaAges 18 years+ - NCT07301411Recruiting
Freezing lung tumors guided by a breathing tube camera
This study tests a new way to freeze and destroy small lung tumors using a thin tube with a camera (bronchoscope) to guide the freezing probe. It is for people with early-stage lung cancer or limited lung metastases who cannot or prefer not to have surgery or radiation.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07306286RecruitingPhase 2
Cryoablation plus immunotherapy for advanced pancreatic cancer
This trial tests combining cryoablation (freezing tumors) with a dual-antibody drug (PD-1/CTLA-4) for people whose locally advanced pancreatic cancer has stopped responding to first-line chemotherapy (AG regimen). The goal is to see if this combination can help control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07306273RecruitingPhase 2
Testing IRE and an immunotherapy drug for advanced pancreatic cancer
This trial tests a new combination: a special electric field treatment (IRE) plus a dual-function antibody (PD-1/CTLA-4) for people with locally advanced pancreatic cancer that didn't respond to standard chemotherapy. The goal is to see if this approach can help shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,313 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.